Acadia Healthcare (ACHC) risk factors, FY2025 10-K

Legal Proceedings and Regulatory Risks

1. 01We are and in the future could become the subject of governmental investigations, regulatory actions, whistleblower lawsuits and other legal proceedings
2. 02We are and in the future may become involved in legal proceedings based on negligence or breach of a contractual or statutory duty from service users or their family members or from employees or former employees
3. 03We carry a large self-insured retention and may be responsible for significant amounts not covered by insurance. In addition, our insurance may be inadequate, premiums may increase and, if there is a significant deterioration in our claims experience, insurance may not be available on acceptable terms
4. 04We handle sensitive personal data which are protected by numerous U.S. laws in the ordinary course of business and any failure to maintain the confidentiality of such data could result in legal liability and reputational harm
5. 05If we fail to comply with extensive laws and government regulations, we could suffer penalties or be required to make significant changes to our operations62% rewritten
6. 06We may be required to spend substantial amounts to comply with statutes and regulations relating to privacy and security of PHI37% rewritten
7. 07We could face risks associated with, or arising out of changing laws and regulations, including those involving environmental, health and safety laws and regulations
8. 08regulate workplace safety
9. 09State efforts to regulate the construction or expansion of healthcare facilities could impair our ability to operate and expand our operations
10. 10We are required to treat patients with emergency medical conditions regardless of ability to pay
11. 11Activist investors and their actions threatened or commenced against us could cause us to incur substantial costs, divert management’s attention and resources, cause uncertainty about the strategic direction of our business and adversely impact our business, financial condition, results of operations and stock priceNew

Financial Risks

1. 12Our revenue and results of operations are significantly affected by payments received from the government and third-party payors
2. 13A significant portion of our revenue is derived from government healthcare programs. For the year ended December 31, 2025, we derived approximately 72% of our revenue from the Medicare and Medicaid programs54% rewritten
3. 14If the rates paid or the scope of services covered by government payors are reduced, there could be a material adverse effect on our business, financial condition and results of operationsNew
4. 15Our debt could adversely affect our financial health and prevent us from fulfilling our obligations under our financing arrangements65% rewritten
5. 16require us to dedicate a substantial portion of our cash flow from operations to payments on our debt (including scheduledNew
6. 17limit our ability to pay dividends, redeem stock or make other distributions
7. 18Servicing our debt requires a significant amount of cash. Our ability to generate sufficient cash to service our debt depends on many factors beyond our control
8. 19We are subject to a number of restrictive covenants, which may restrict our business and financing activities
9. 20merge or consolidate with other companies
10. 21Despite our current debt level, we may incur significant additional amounts of debt, which could further exacerbate the risks associated with our debt43% rewritten
11. 22If we default on our obligations to pay our debt, we may not be able to make payments on our financing arrangements
12. 23We may be required to record additional charges to future earnings if our goodwill, intangible assets and property and equipment become impaired36% rewritten
13. 24Our operating costs are subject to increases in the wages and salaries of our staff
14. 25We are subject to volatility in the global capital and credit markets as well as significant developments in macroeconomic and political conditions that are out of our control, including any effects that a U.S. government shutdown, tariffs or trade disputes may have on financial markets and macroeconomic conditions
15. 26A worsening of the economic and employment conditions in the geographies in which we operate could materially affect our business and future results of operations
16. 27Increased inflationary pressure may adversely impact our business, financial condition and results of operations38% rewritten
17. 28The industry trend on value-based purchasing may negatively impact our revenue
18. 29The trend by insurance companies and managed care organizations to enter into sole-source contracts may limit our ability to obtain patients
19. 30An increase in uninsured or underinsured patients, from healthcare policy changes or otherwise, or the deterioration in the collectability of patient accounts receivables could harm our results of operations53% rewritten
20. 31Failure to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) could have a material adverse effect on our business
21. 32We do not anticipate paying any cash dividends in the foreseeable future

Operational Risks

1. 33An incident involving one or more of our patients or the failure by one or more of our facilities to provide appropriate care could result in increased regulatory burdens, governmental investigations, litigation, negative publicity and adversely affect the trading price of our common stock
2. 34Joint ventures may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities
3. 35Our ability to grow our business through organic expansion is dependent on capacity and occupancy at our facilities. Should our facilities reach maximum occupancy, we may need to implement other growth strategies either by developing de novo or joint venture facilities or by modifying existing facilities
4. 36Our business growth and acquisition strategies expose us to a variety of operational and financial risks
5. 37Integrating a newly acquired facility could be expensive and time consuming and could disrupt our ongoing business, negatively affect cash flow and distract management and other key personnel from day-to-day operations
6. 38Benefits may not materialize
7. 39Assumptions of unknown liabilities
8. 40Competing for acquisitions
9. 41Antitrust and other legal challenges
10. 42We incur significant transaction-related costs in connection with acquisitions and other strategic transactions
11. 43We care for a large number of vulnerable individuals with complex needs and any care quality deficiencies could adversely impact our brand, reputation and ability to market our services effectively
12. 44The cost of construction materials and labor has significantly increased, and we continue to grow our business through expansion of existing facilities and development of de novo and joint venture facilities
13. 45Our business could be disrupted if our information systems fail or if our databases are destroyed or damaged
14. 46If we do not continually enhance our facilities with the most recent technological advances, our ability to maintain and expand our markets will be adversely affected
15. 47A cybersecurity incident could have a material adverse impact on us, including substantial sanctions, fines, and damages and civil and criminal penalties under federal and state privacy laws, in addition to reputational harm and increased costs
16. 48We may fail to deal with clinical waste in accordance with applicable regulations or otherwise be in breach of relevant medical, health and safety or environmental laws and regulations
17. 49Although we have facilities in 40 states and Puerto Rico, we have substantial operations in Pennsylvania, California and Tennessee, which makes us especially sensitive to regulatory, economic, environmental and competitive conditions and changes in those states54% rewritten
18. 50Our business and operations are subject to risks related to natural disasters and climate change
19. 51A pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate or that otherwise impacts our facilities could adversely impact our business
20. 52If we fail to cultivate new or maintain established relationships with referral sources, our business, financial condition and results of operations could be adversely affected
21. 53We operate in a highly competitive industry, and competition may lead to declines in patient volumes
22. 54We may be unable to extend leases at expiration, which could harm our business, financial condition or results of operations
23. 55Controls designed to reduce inpatient services may reduce our revenue
24. 56We are a holding company with no operations and rely upon our subsidiaries to provide us with the funds necessary to meet our financial obligations. Liabilities of any one or more of our subsidiaries could be imposed upon us or our other subsidiaries

Human Capital Risks

1. 57Our facilities face competition for staffing, labor shortages and higher turnover rates that may increase our labor costs and reduce our profitability
2. 58Our performance depends on our ability to recruit and retain quality psychiatrists and other physicians, and nurses, counselors and other medical support personnel
3. 59Some of our employees are represented by labor unions and any work stoppage could adversely affect our business20% rewritten
4. 60We depend on key management personnel, and the failure to attract and retain one or more of our key executives, including our Chief Executive Officer, or a significant portion of our local facility management personnel could harm our business60% rewritten
5. 61The market price of our common stock has been, and may continue to be, volatile and could be subject to wide fluctuations in response to our operating results, quarter to quarter earnings, the risk factors described in this Annual Report on Form 10-K and other factors outside of our controlNew
6. 62Future sales of common stock by us or our existing stockholders may cause our stock price to fall
7. 63If securities or industry analysts do not publish research or reports about our business, if they were to change their recommendations regarding our stock adversely or if our operating results do not meet their expectations, our stock price and trading volume could decline
8. 64We incur substantial costs as a result of being a public company
9. 65Provisions of our charter documents or Delaware law could delay or prevent an acquisition of us, even if the acquisition would be beneficial to our stockholders, and could make it more difficult for stockholders to change management
10. 66the authority of the board of directors to issue preferred stock with such terms as the board of directors may determine